Rekombinanter CA9 Antikörper (full length)
Kurzübersicht für Rekombinanter CA9 Antikörper (full length) (ABIN7877771)
Target
Alle CA9 Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- Recombinant Carbonic Anhydrase 9 Antibody / CA9
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human CA9 protein was used as the immunogen for the recombinant Carbonic Anhydrase 9 antibody.
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant Carbonic Anhydrase 9 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant Carbonic Anhydrase 9 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CA9 (Carbonic Anhydrase IX (CA9))
-
Andere Bezeichnung
- Carbonic Anhydrase 9
-
Hintergrund
- In normal kidney, CA9 is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Reportedly, CA9 is expressed by 93 % of primary and 84 % of metastatic renal cell carcinomas. This MAb may be useful in the investigations of carcinomas of proximal nephrogenic differentiation especially those showing tubular differentiation.
-
UniProt
- Q16790
Target
-